As of October 2024, Protagonist Therapeutics has a market cap of $2.66B. This makes Protagonist Therapeutics the world's 4312th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.61B | 22.11% |
2023 | $1.32B | 110.17% |
2022 | $629.27M | -68.10% |
2021 | $1.97B | 69.64% |
2020 | $1.16B | 185.96% |
2019 | $406.63M | 4.75% |
2018 | $388.17M | -67.64% |
2017 | $1.20B | -5.41% |
2016 | $1.27B | - |